Medicinal Cannabis Matters – A weekly round-up.
Medicinal Cannabis Matters | Friday roundup 17th May 2024.
Medicinal Cannabis Matters – Our weekly round-up of what has been happening in the world of medicinal cannabis this week.
This week we explore what the pros and cons of a cannabis card are, how according to studies medicinal cannabis is now the best solution for migraines and we look at the US reclassifying marijuana as a low-risk drug.
What are the pros and cons of a cannabis card?
The reasoning behind a cannabis card is to allow patients who have been recommended medicinal cannabis by their Doctor to be able to carry medical cannabis with no repercussions. There were several cannabis cards to start with but today Cancard is the only one that still exists. This article explores some of the pros and cons of a cannabis card.
Medicinal cannabis is now the best solution for migraines according to 3 new medical studies.
Medicinal cannabis has been shown to be effective in the treatment of migraines and there are several studies that back this up. The majority of users have said it has helped their symptoms, and 63% of people have said that cannabis consumption also helped them decrease or completely eliminate their prescription medications for migraines.
The US proposes reclassifying marijuana as a low-risk drug.
President Joe Biden’s administration formally proposed on Thursday reclassifying marijuana as a less dangerous drug and have classed the reclassification as historic contributing to the decriminalisation of cannabis.
Disclaimer:
This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.
